Collegium Pharmaceutical Stock Technical Analysis

COLL Stock  USD 30.50  0.21  0.68%   
As of the 30th of November, Collegium Pharmaceutical shows the Risk Adjusted Performance of (0.08), standard deviation of 2.36, and Mean Deviation of 1.87. Collegium Pharmaceutical technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Collegium Pharmaceutical standard deviation and value at risk to decide if Collegium Pharmaceutical is priced correctly, providing market reflects its regular price of 30.5 per share. Given that Collegium Pharmaceutical has information ratio of (0.17), we suggest you to validate Collegium Pharmaceutical's prevailing market performance to make sure the company can sustain itself at a future point.

Collegium Pharmaceutical Momentum Analysis

Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Collegium, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to Collegium
  
Collegium Pharmaceutical's Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.

Collegium Pharmaceutical Analyst Consensus

Target PriceAdvice# of Analysts
33.5Buy5Odds
Collegium Pharmaceutical current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Collegium analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Collegium stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Collegium Pharmaceutical, talking to its executives and customers, or listening to Collegium conference calls.
Collegium Analyst Advice Details
Collegium Pharmaceutical technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Collegium Pharmaceutical technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Collegium Pharmaceutical trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Collegium Pharmaceutical Technical Analysis

Indicator
Time Period
Execute Indicator
The output start index for this execution was ten with a total number of output elements of fifty-one. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Collegium Pharmaceutical volatility. High ATR values indicate high volatility, and low values indicate low volatility.

Collegium Pharmaceutical Trend Analysis

Use this graph to draw trend lines for Collegium Pharmaceutical. You can use it to identify possible trend reversals for Collegium Pharmaceutical as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Collegium Pharmaceutical price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.

Collegium Pharmaceutical Best Fit Change Line

The following chart estimates an ordinary least squares regression model for Collegium Pharmaceutical applied against its price change over selected period. The best fit line has a slop of   0.15  , which may suggest that Collegium Pharmaceutical market price will keep on failing further. It has 122 observation points and a regression sum of squares at 907.2, which is the sum of squared deviations for the predicted Collegium Pharmaceutical price change compared to its average price change.

About Collegium Pharmaceutical Technical Analysis

The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Collegium Pharmaceutical on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Collegium Pharmaceutical based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Collegium Pharmaceutical price pattern first instead of the macroeconomic environment surrounding Collegium Pharmaceutical. By analyzing Collegium Pharmaceutical's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Collegium Pharmaceutical's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Collegium Pharmaceutical specific price patterns or momentum indicators. Please read more on our technical analysis page.
 2023 2024 (projected)
Dividend Yield0.07480.0721
Price To Sales Ratio1.831.74

Collegium Pharmaceutical November 30, 2024 Technical Indicators

Most technical analysis of Collegium help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Collegium from various momentum indicators to cycle indicators. When you analyze Collegium charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

Collegium Pharmaceutical November 30, 2024 Daily Trend Indicators

Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Collegium stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
When determining whether Collegium Pharmaceutical is a strong investment it is important to analyze Collegium Pharmaceutical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Collegium Pharmaceutical's future performance. For an informed investment choice regarding Collegium Stock, refer to the following important reports:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Collegium Pharmaceutical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
For more information on how to buy Collegium Stock please use our How to buy in Collegium Stock guide.
You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Collegium Pharmaceutical. If investors know Collegium will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Collegium Pharmaceutical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.49)
Earnings Share
2.34
Revenue Per Share
18.538
Quarterly Revenue Growth
0.165
Return On Assets
0.0968
The market value of Collegium Pharmaceutical is measured differently than its book value, which is the value of Collegium that is recorded on the company's balance sheet. Investors also form their own opinion of Collegium Pharmaceutical's value that differs from its market value or its book value, called intrinsic value, which is Collegium Pharmaceutical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Collegium Pharmaceutical's market value can be influenced by many factors that don't directly affect Collegium Pharmaceutical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Collegium Pharmaceutical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Collegium Pharmaceutical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Collegium Pharmaceutical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.